[Genistein in chemoprevention and treatment]

Michał Tarkowski1, Mirosława Kokocińska, Małgorzata Latocha

  • 1Slaski Uniwersytet Medyczny w Katowicach, Zaklad Biologii Komórki.

Insights

Genistein, a soy isoflavone, shows potential in cancer prevention and managing menopausal symptoms. Further research is needed to optimize its therapeutic use through precise dosing.

Area of Science:

  • Biochemistry and Molecular Biology
  • Nutritional Science
  • Pharmacology

Context:

  • Genistein is a prominent isoflavone found abundantly in soy products, a staple in Asian diets.
  • Emerging research highlights genistein's multifaceted biological activities with potential health implications.
  • Its role in mitigating menopausal estrogen deficiency symptoms warrants further investigation.

Purpose:

  • To explore the diverse biological activities of genistein, including its effects on cellular processes relevant to cancer and hormonal health.
  • To investigate genistein's influence on oxidative stress, carcinogen metabolism, cell cycle regulation, apoptosis, angiogenesis, inflammation, and immune responses.
  • To establish optimal genistein dosage and treatment duration for maximizing therapeutic efficacy.

Summary:

  • Genistein exhibits significant anticancer properties by protecting cells against malignant transformation, inhibiting tumor cell proliferation, and inducing apoptosis.
  • This soy-derived compound also demonstrates efficacy in alleviating side effects associated with menopausal estrogen deficiency.
  • Key mechanisms include modulation of free radicals, reactive oxygen species, carcinogen metabolism, cell cycle progression, apoptosis, angiogenesis, and immune responses.

Impact:

  • Genistein represents a promising natural compound for both cancer chemoprevention and hormone replacement therapy alternatives.
  • Understanding genistein's dose-response relationship is critical for its successful clinical application.
  • Further research into genistein's therapeutic potential could lead to novel dietary and pharmacological interventions.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...